Table 1 Population description for the KB and IGR hospitals and association between variables measured at admission and severity.

From: Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients

 

KB, N = 837

IGR, N = 150

Pooled

 

Distribution

Odds ratio

p-value association with severity

Distribution

Odds ratio

p-value association with severity

Pooled p-value

Significant association

Outcomes

Severity: “Intubation” OR “O2 ≥ 15 L” OR “Death”

30% [817]

 

32% [144]

 

 

Intubation

13% [837]

 

11% [150]

 

 

O2 ≥ 15 L

15% [837]

 

11% [150]

 

 

Death

17% [837]

 

17% [150]

 

 

Clinical characteristics

Age

63.0 (52.0, 77.0) [833]

1.61 (1.37, 1.90)

7.32 × 10−09

6.10 (49.0, 71.0) [149]

1.35 (0.92, 1.98)

1.29 × 10−01

2.54 × 10−09

Yes

Sex

57% [837]

1.97 (1.43, 2.72)

3.03 × 10−05

49% [150]

1.07 (0.51, 2.23)

8.67 × 10−01

3.52 × 10−05

Yes

BMI

27.0 (23.5, 31.1) [400]

1.17 (0.95, 1.43)

1.39 × 10−01

24.9 (21.5, 27.7) [108]

1.28 (0.81, 2.00)

2.87 × 10−01

1.00 × 10−01

 

Height

1.7 (1.6, 1.8) [404]

1.18 (0.96, 1.46)

1.13 × 10−01

1.7 (1.6, 1.8) [109]

1.08 (0.69, 1.71)

7.30 × 10−01

1.05 × 10−01

 

Weight

75.0 (62.0, 90.0) [543]

1.08 (0.91, 1.29)

3.84 × 10−01

72.0 (60.0, 85.0) [119]

1.31 (0.86, 1.99)

2.06 × 10−01

2.81 × 10−01

 

Clinical examination

Oxygen saturation

95.0 (90.0, 97.0) [783]

0.37 (0.30, 0.45)

6.42 × 10−20

97.0 (94.0, 99.0) [132]

0.35 (0.20, 0.63)

4.33 × 10−04

7.32 × 10−22

Yes

Diastolic pressure

80.0 (69.0, 90.0) [769]

0.70 (0.60, 0.83)

3.93 × 10−05

78.0 (69.0, 84.8) [138]

0.75 (0.51, 1.11)

1.55 × 10−01

1.74 × 10−05

Yes

Respiratory rate

25.0 (20.0, 30.0) [667]

1.33 (1.12, 1.58)

1.10 × 10−03

22.0 (18.0, 28.0) [67]

3.37 (1.28, 8.86)

1.39 × 10−02

2.70 × 10−04

Yes

Systolic pressure

134.0 (118.0, 148.0) [769]

0.82 (0.70, 0.97)

1.84 × 10−02

125.0 (113.5, 137.5) [139]

0.74 (0.50, 1.10)

1.37 × 10−01

9.87 × 10−03

 

Cardiac frequency

95.0 (82.0, 107.0) [771]

0.94 (0.80, 1.10)

4.29 × 10−01

90.0 (80.0, 102.2) [136]

1.27 (0.86, 1.87)

2.33 × 10−01

5.68 × 10−01

 

Body temperature

37.8 (37.0, 38.5) [788]

0.99 (0.84, 1.17)

9.28 × 10−01

37.3 (36.7, 38.0) [137]

6.09 (0.97, 38.36)

5.44 × 10−02

8.07 × 10−01

 

Symptoms

Dyspnea

68% [837]

1.73 (1.23, 2.45)

1.87 × 10−03

57% [150]

1.67 (0.78, 3.59)

1.88 × 10−01

9.93 × 10−04

 

Chest pain

8.2% [837]

0.27 (0.12, 0.61)

1.54 × 10−03

5.3% [150]

0.78 (0.15, 4.04)

7.68 × 10−01

1.52 × 10−03

 

Myalgia

24% [837]

0.59 (0.41, 0.86)

6.20 × 10−03

13% [150]

0.99 (0.32, 3.01)

9.83 × 10−01

6.95 × 10−03

 

Confusion

9.4% [837]

1.73 (1.06, 2.81)

2.80 × 10−02

2.7% [150]

7.62 (0.77, 75.63)

8.28 × 10−02

1.37 × 10−02

 

Coughing

41% [837]

0.78 (0.57, 1.06)

1.10 × 10−01

31% [150]

0.88 (0.40,1.97)

7.64 × 10−01

1.04 × 10−01

 

Diarrhea

8.0% [837]

1.30 (0.76, 2.24)

3.42 × 10−01

6.0% [150]

1.20 (0.21, 6.82)

8.39 × 10−01

3.31 × 10−01

 

Fever

51% [837]

1.11 (0.82, 1.50)

4.98 × 10−01

37% [150]

1.53 (0.71, 3.26)

2.75 × 10−01

3.92 × 10−01

 

Asthenia

17% [837]

0.78 (0.51, 1.18)

2.41 × 10−01

8.0% [150]

3.18 (0.91, 11.09)

7.01 × 10−02

4.01 × 10−01

 

Symptoms duration before examination

6.0 (3.0, 9.0) [771]

1.02 (0.87, 1.19)

8.13 × 10−01

4.0 (2.0, 7.8) [126]

1.15 (0.78, 1.68)

4.76 × 10−01

7.21 × 10−01

 

Dry quintuous cough

33% [837]

0.95 (0.69, 1.31)

7.43 × 10−01

20% [150]

1.23 (0.48, 3.17)

6.62 × 10−01

8.05 × 10−01

 

Headache

5.3% [837]

1.09 (0.57, 2.09)

8.04 × 10−01

3.3% [150]

0.58 (0.06, 5.39)

6.35 × 10−01

8.72 × 10−01

 

Comorbidities and smoking

Chronic kidney disease

12% [837]

2.39 (1.54, 3.70)

9.51 × 10−05

7.3% [150]

16.59 (1.93, 142.84)

1.06 × 10−02

1.81 × 10−05

Yes

Hypertension

45% [837]

1.77 (1.31, 2.40)

2.43 × 10−04

35% [150]

1.11 (0.51, 2.42)

7.9 × 10−01

2.52 × 10−04

Yes

Asthma

8.7% [837]

0.41 (0.21, 0.80)

8.87 × 10−03

6.0% [150]

0.32 (0.04, 2.71)

2.97 × 10−01

5.81 × 10−03

 

Cardiac disease

22% [837]

1.41 (0.99, 2.02)

5.77 × 10−02

17% [150]

1.05 (0.39, 2.78)

9.26 × 10−01

5.94 × 10−02

 

Diabetes

24% [837]

1.32 (0.94, 1.87)

1.13 × 10−01

19% [150]

2.10 (0.83, 5.30)

1.15 × 10−01

6.66 × 10−02

 

Smoker

15% [837]

1.32 (0.87, 2.00)

1.88 × 10−01

25% [150]

2.85 (1.26, 6.44)

1.17 × 10−02

8.30 × 10−02

 

Emphysema

6.0% [837]

1.47 (0.80, 2.71)

2.12 × 10−01

14% [150]

4.12 (1.51, 11.25)

5.62 × 10−03

8.73 × 10−02

 

Corticosteroids

3.9% [837]

0.61 (0.26, 1.43)

2.57 × 10−01

12% [150]

3.14 (1.05, 9.37)

3.99 × 10−02

4.48 × 10−01

 

Chemotherapy

1.0% [837]

1.39 (0.33, 5.88)

6.50 × 10−01

39% [150]

1.88 (0.89, 3.98)

9.94 × 10−02

4.64 × 10−01

 

Dyslipidemia

16% [837]

1.09 (0.73, 1.65)

6.71 × 10−01

11% [150]

2.67 (0.87, 8.18)

8.65 × 10−02

4.74 × 10−01

 

NSAI

3.6% [837]

1.23 (0.56, 2.68)

6.05 × 10−01

0.7% [150]

0 (0, lnf)

9.88 × 10−01

6.13 × 10−01

 

Cancer

7.3% [837]

1.17 (0.66, 2.08)

5.87 × 10−01

85% [150]

0.47 (0.17, 1.30)

1.45 × 10−01

7.78 × 10−01

 

Biological measures

LDH

341.0 (263.5, 452.5) [527]

2.02 (1.63, 2.51)

1.51 × 10−10

278.0 (203.8, 400.0) [134]

2.36 (1.32, 4.21)

3.77 × 10−03

9.78 × 10−12

Yes

Urea

6.0 (4.2, 9.8) [739]

1.66 (1.40, 1.97)

5.72 × 10−09

5.1 (3.7, 6.9) [117]

2.19 (1.36, 3.52)

1.28 × 10−03

3.07 × 10−10

Yes

CRP

69.0 (29.0, 130.0) [729]

1.48 (1.27, 1.74)

1.07 × 10−06

52.7 (15.1, 115.7) [142]

1.48 (1.03, 2.14)

3.64 × 10−02

2.37 × 10−07

Yes

Neutrophil

5.0 (3.5, 7.1) [746]

1.38 (1.18, 1.62)

8.31 × 10−05

4.4 (2.3, 7.1) [148]

1.15 (0.80, 1.64)

4.51 × 10−01

6.16 × 10−05

Yes

Leukocytes

6.7 (4.9, 9.0) [750]

1.31 (1.12, 1.54)

7.18 × 10−04

6.6 (4.1, 9.8) [144]

1.19 (0.83, 1.71)

3.43 × 10−01

4.73 × 10−04

Yes

Platelet

206.0 (161.5, 259.5) [751]

0.78 (0.66, 0.93)

5.47 × 10−03

213.5 (156.0, 308.0) [144]

0.76 (0.50, 1.15)

1.93 × 10−01

3.06 × 10−03

 

Ferritin

627.0 (287.8, 1285.5) [296]

1.27 (0.99, 1.62)

6.33 × 10−02

567.0 (233.0, 1327.0) [125]

1.52 (1.03, 2.26)

3.70 × 10−02

2.85 × 10−02

 

Total bilirubin

8.0 (6.0, 11.0) [691]

1.16 (0.99, 1.37)

6.80 × 10−02

9.0 (6.0, 13.0) [137]

1.52 (1.04, 2.23)

3.25 × 10−02

3.01 × 10−02

 

Conjugated bilirubin

12.0 (9.0, 16.0) [57]

1.32 (0.72, 2.42)

3.63 × 10−01

2.0 (2.0, 5.0) [68]

2.00 (1.10, 3.65)

2.29 × 10−02

1.97 × 10−01

 

Lymphocyte

1.0 (0.7, 1.4) [745]

0.89 (0.70, 1.12)

3.16 × 10−01

1.0 (0.6, 1.6) [148]

0.80 (0.53, 1.21)

2.89 × 10−01

2.42 × 10−01

 

Monocyte

0.5 (0.3, 0.6) [746]

0.93 (0.79, 1.10)

3.99 × 10−01

0.5 (0.3, 0.8) [148]

0.66 (0.36, 1.19)

1.64 × 10−01

2.84 × 10−01

 

Hemoglobin

13.2 (12.1, 14.4) [751]

1.06 (0.90, 1.24)

4.84 × 10−01

11.1 (9.5, 12.8) [144]

0.65 (0.43, 0.98)

3.79 × 10−02

7.43 × 10−01

 

Creatine kinase

146.0 (84.0, 312.8) [638]

0.98 (0.82, 1.18)

8.47 × 10−01

70.5 (30.8, 157.2) [92]

1.32 (0.83, 2.10)

2.36 × 10−01

9.88 × 10−01

 

Radiological standardized report

Disease extent 0/1/2/3/4/5

6.3/17/37/27/11/2.6% [806]

2.43 (2.01, 2.93)

2.13 × 10−20

14/36/24/7.2/10/8.7% [138]

1.62 (1.11, 2.37)

1.21 × 10−02

1.28 × 10−21

Yes

Crazy paving

44% [799]

2.72 (1.98, 3.74)

6.48 × 10−10

40% [140]

2.37 (1.10, 5.11)

2.72 × 10−02

9.94 × 10−11

Yes

Peripheral distribution

63% [749]

0.52 (0.38, 0.72)

7.84 × 10−05

32% [137]

0.55 (0.23, 1.31)

1.77 × 10−01

3.73 × 10−05

Yes

Predominance inferior

40% [732]

1.46 (1.06, 2.02)

2.13 × 10−02

43% [136]

0.90 (0.42, 1.93)

7.81 × 10−01

2.65 × 10−02

 

GGO

91% [824]

1.72 (0.94, 3.17)

8.02 × 10−02

76% [140]

1.55 (0.60, 3.98)

3.66 × 10−01

6.01 × 10−02

 

Consolidation

69% [773]

1.36 (0.95, 1.94)

9.23 × 10−02

39% [140]

1.13 (0.53, 2.41)

7.56 × 10−01

8.69 × 10−02

 

GGO rounded

15% [750]

0.64 (0.40, 1.03)

6.63 × 10−02

7.5% [107]

3.10 (0.65, 14.75)

1.56 × 10−01

1.18 × 10−01

 

Consolidation rounded

17& [535]

1.08 (0.66, 1.77)

7.59 × 10−01

18% [55]

0.92 (0.21, 4.09)

9.11 × 10−01

7.77 × 10−01

 

Other radiological patterns

Cardiomegaly

25% [115]

2.84 (1.19, 6.80)

1.89 × 10−02

23% [78]

0.77 (0.22, 2.72)

7.40 × 10−01

2.42 × 10−02

 

Splenomegaly

2.6% [115]

4.11 (0.36, 46.85)

2.55 × 10−01

10% [78]

17.33 (1.88, 160)

1.40 × 10−02

1.22 × 10−01

 

Hepatomegaly

8.7% [115]

1.35 (0.36, 5.12)

6.56 × 10−01

18% [78]

5.17 (1.41, 18.99)

2.02 × 10−02

4.00 × 10−01

 

COVID treatment

Corticoid

1.0% [837]

  

4.7% [150]

    

Hydroxychloroquine

4.1% [837]

  

34% [150]

    

Immunomodulator

2.5% [837]

  

0% [144]

    

Kaletra

1.4% [837]

  

2.0% [150]

    

Anti-IL6

3.2% [837]

  

4.7% [150]

    

Interferon

0.6% [837]

  

0% [144]

    
  1. Among the 1003 patients of the study, biological and clinical variables were available for 987 individuals. Categorical variables are expressed as percentages [available]. Continuous variables are shown as median (IQR) [available]. Associations with severity are evaluated with logistic regression and reported with two-sided p-values for each center and p-values were combined with Stouffer’s method. The column entitled “Significant association” indicates that the variable is significantly associated with severity after Bonferroni adjustment to account for multiple testing across 58 variables (treatments are excluded). For continuous variables, odds ratios are computed for an increase of one standard deviation of the continuous variable.